Risk factors of liver and gastrointestinal adverse events in patients treated with Ipilimumab + Nivolumab

Project: Research

Project Details

StatusFinished
Effective start/end date7/01/2228/02/25

Funding

  • Bristol-Myers Squibb Australia Pty Ltd.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.